HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intra-articular radiation synovectomy.

Abstract
Fifty-three knees in 44 patients with severe, chronic rheumatoid arthritis (RA) were treated by the instillation of an intra-articular radionuclide (dysprosium-165; 165Dy) coupled with a large, relatively inert carrier (ferric hydroxide macroaggregate). The extremely low leakage rates found in earlier animal experiments were confirmed in the human, with a mean leakage rate of 0.3% of the injected dose. This leakage corresponds to a total body dose of 0.4 rad and a liver dose of 2.5 rad, equivalent to a lumbosacral series of diagnostic radiographs. Eighty percent of the treated knees showed improvement, which was maintained as long as one year after treatment. There was a direct correlation between the preoperative radiographic stage and the response to treatment, with patients in Stages I and II more likely to have a good or excellent response at one year. There was also good correlation between clinical improvement and improvement in technetium-99m (99mTc)-pertechnetate flow scintigraphy. Chemical synovectomy by the instillation of appropriate radionuclides can be recommended as an effective means of reducing inflammation, effusion, and pain in patients with RA. The duration of favorable results cannot be predicted, but the results to date suggest that longevity should be comparable with that of surgical synovectomy. Like surgical synovectomy, radiation synovectomy is most effective in the early stages of the disease process, before there is extensive destruction of cartilage and bone.
AuthorsC B Sledge, R W Atcher, S Shortkroff, R J Anderson, W D Bloomer, B J Hurson
JournalClinical orthopaedics and related research (Clin Orthop Relat Res) 1984 Jan-Feb Issue 182 Pg. 37-40 ISSN: 0009-921X [Print] United States
PMID6319062 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Ferric Compounds
  • Radioisotopes
  • Dysprosium
  • ferric hydroxide
  • Technetium
  • Sodium Pertechnetate Tc 99m
Topics
  • Adolescent
  • Adult
  • Aged
  • Arthritis, Rheumatoid (radiotherapy)
  • Dysprosium (administration & dosage)
  • Evaluation Studies as Topic
  • Female
  • Ferric Compounds (administration & dosage)
  • Humans
  • Knee Joint (diagnostic imaging)
  • Male
  • Middle Aged
  • Radiation Dosage
  • Radioisotopes (administration & dosage)
  • Radionuclide Imaging
  • Sodium Pertechnetate Tc 99m
  • Synovial Membrane (radiation effects)
  • Synovitis (radiotherapy)
  • Technetium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: